We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$49.6B
AUM Growth
+$5.62B
(+13%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,885
New
111
Increased
738
Reduced
863
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$178M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$161M |
| 3 |
KLA
KLAC
|
+$151M |
| 4 |
Zions Bancorporation
ZION
|
+$148M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$85.6M |
| 2 |
Keysight
KEYS
|
+$83.3M |
| 3 |
ATI
ATI
|
+$81.4M |
| 4 |
Kennametal
KMT
|
+$66.6M |
| 5 |
Keurig Dr Pepper
KDP
|
+$65.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Industrials | 15.08% |
| 3 | Technology | 14.03% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
KRONOS Worldwide
KRO
$686M
| $710K | ﹤0.01% |
46,316
-3,619
| -7% | -$50.2K |
|
1302
Argan
AGX
$8.73B
| $704K | ﹤0.01% |
17,345
-1,357
| -7% | -$63.6K |
|
1303
Acco Brands
ACCO
$396M
| $695K | ﹤0.01% |
88,333
-6,904
| -7% | -$56.6K |
|
1304
Buckle
BKE
$2.36B
| $688K | ﹤0.01% |
39,763
-3,103
| -7% | -$54.5K |
|
1305
Moelis & Co
MC
$5.13B
| $679K | ﹤0.01% |
19,423
-1,519
| -7% | -$54.9K |
|
|
SNNA
1306
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $665K | ﹤0.01% |
764,610
-35,390
| -4% | -$55.4K |
|
1307
Equinix
EQIX
$103B
| $655K | ﹤0.01% |
1,299
-337
| -21% | -$162K |
|
1308
The Greenbrier Companies
GBX
$1.56B
| $653K | ﹤0.01% |
21,469
-602,024
| -97% | -$19.1M |
|
|
IVC
1309
DELISTED
Invacare Corporation
IVC
| $633K | ﹤0.01% |
121,995
+23,861
| +24% | +$156K |
|
|
HEES
1310
DELISTED
H&E Equipment Services
HEES
| $601K | ﹤0.01% |
20,674
-1,616
| -7% | -$45K |
|
1311
Morningstar
MORN
$7.52B
| $598K | ﹤0.01% |
4,136
+3,468
| +519% | +$479K |
|
|
EVLO
1312
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $575K | ﹤0.01% |
3,201
-1,168
| -27% | -$189K |
|
1313
Ford
F
$57.2B
| $574K | ﹤0.01% |
56,087
-1,158
| -2% | -$11.4K |
|
1314
Hooker Furnishings Corp
HOFT
$163M
| $574K | ﹤0.01% |
27,817
-2,178
| -7% | -$58.6K |
|
1315
Global Industrial
GIC
$1.44B
| $573K | ﹤0.01% |
25,877
-2,024
| -7% | -$44.3K |
|
|
USAK
1316
DELISTED
USA Truck Inc
USAK
| $567K | ﹤0.01% |
56,065
+10,180
| +22% | +$134K |
|
1317
PetMed Express
PETS
$42.5M
| $564K | ﹤0.01% |
36,003
-2,816
| -7% | -$55.4K |
|
|
ALPN
1318
DELISTED
Alpine Immune Sciences Inc
ALPN
| $552K | ﹤0.01% |
131,022
-3,520
| -3% | -$20.3K |
|
|
DSKE
1319
DELISTED
Daseke, Inc. Common Stock
DSKE
| $551K | ﹤0.01% |
153,176
+29,500
| +24% | +$140K |
|
|
WBC
1320
DELISTED
WABCO HOLDINGS INC.
WBC
| $541K | ﹤0.01% |
4,077
-17,148
| -81% | -$2.26M |
|
1321
Methanex
MEOH
$4.07B
| $532K | ﹤0.01% |
+11,700
| New | +$587K |
|
1322
Dow Inc
DOW
$21.4B
| $531K | ﹤0.01% |
+10,764
| New | +$568K |
|
|
AQ
1323
DELISTED
Aquantia Corp. Common Stock
AQ
| $529K | ﹤0.01% |
+40,614
| New | +$475K |
|
1324
Autodesk
ADSK
$50.2B
| $512K | ﹤0.01% |
3,143
-66
| -2% | -$11.1K |
|
1325
Campbell Soup
CPB
$6.78B
| $507K | ﹤0.01% |
12,663
+9,840
| +349% | +$386K |
|
Similar funds
Victory Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Victory Capital Management held 1,885 positions worth $49.6B, up 13% from $44B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Victory Capital Management deployed $2.56B of net new capital in Q2 2019, opening 111 new positions and adding to 738 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Ingredion, an estimated $85.6M trimmed.
- Victory Capital Management's largest Q2 2019 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
- Victory Capital Management added most to KLA in Q2 2019, an estimated $151M increase.
- Victory Capital Management's biggest Q2 2019 reduction was Ingredion, cutting an estimated $85.6M.
- Victory Capital Management fully exited Teladoc Health in Q2 2019, selling an estimated $50.5M.
- Victory Capital Management's ten largest holdings make up 6.8% of its $49.6B portfolio in Q2 2019.
- Victory Capital Management opened 111 new positions and closed 63 in Q2 2019.
- Victory Capital Management's portfolio value rose 13% quarter-over-quarter to $49.6B.
Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.